Mind Medicine Australia FREE Webinar: From Research to Practice: A Journey into Psychedelic-Assisted Therapies and Emerging Career Paths

Don’t miss out – Get your tickets early!

Join our upcoming FREE Webinar with Dr Stephen Proud, Dr David Erritzoe (UK), Reece Flowers, Trudi Hayes and Scott Edwards.

If you are a CPAT Graduate or a therapist, doctor, clinician or Allied Health practitioner considering training in Psychedelic-Assisted Therapies, don’t miss this free Webinar!

This free Webinar is open to everyone, including CPAT graduates, current CPAT students and professionals considering completing the world-leading Certificate in Psychedelic-Assisted Therapies (CPAT).

CPAT by Mind Medicine Australia (MMA) is a hybrid training for registered healthcare professionals, combining online and face-to-face components. It equips prescribing psychiatrists and other mental health professionals with the necessary skills to safely administer psychedelic-assisted therapies in clinical settings, fostering a multidisciplinary approach to treatment. It features a world-class Faculty. Many of the over 600 graduates say it is the best professional development training program they have undertaken.

Attend this informative Webinar, From Research to Practice: A Journey into Psychedelic-Assisted Therapies and Emerging Career Paths on April 16 with our world-renowned faculty and experts to discover emerging career opportunities, essential skills, and the future of Psychedelic-Assisted Therapies. Whether you’re a student, a professional or simply interested in learning more, this session will provide valuable insights into integrating science, holistic healing, and innovative care models.

In this session, we will cover:

• Translating Scientific Research into Clinical Practice: Bridging the gap between psychedelic-assisted therapy research and therapeutic application, adapting within clinical settings to support integrative and holistic healing

• Core Competencies for Psychedelic-Assisted Therapy Practitioners: Foundational skills including trauma-informed care, cultural sensitivity, somatic awareness, self-awareness, embodying loving presence and more

• Building a Career in Psychedelic-Assisted Therapies: Emerging pathways and opportunities: Exploring emerging career pathways, merging scientific insight with spiritual/indigenous wisdom, collaborative and interdisciplinary models of care, training, accreditation and supervision including hearing from a CPAT graduate and their journey implementing PAT into their practice.

• The Therapeutic Alliance in Psychedelic-Assisted Therapies: The importance of creating a deep sense of safety in the therapeutic relationship in both individual and group settings

• Future Directions: Ethics, Accessibility, and Community: Navigating ethical considerations, advocating for balanced medicalisation, building an equitable and accessible model

EVENT DETAILS

• DATE: 15th April 2026

• TIME: 6:55pm (AEST) for 7:00pm start, finishing at 8:15pm

• DURATION: 75 minutes (incl Q&A)

• LOCATION: Online - a link will be emailed to you with the viewing details

A replay of the event will be made available on our YouTube channel.

ABOUT THE PRESENTER

Dr Stephen Proud
Psychiatrist

Stephen Proud is a psychiatrist in private practice in regional WA with 45 years’ experience in medicine and 25 years as a psychiatrist. He has 3 sons. He has worked as a GP in rural WA, Perth and rural Zululand South Africa. He has taught GPs and psychiatric registrars for many years in Perth. He has built and run two psychiatric hospitals, one in Perth and the other an innovative rural retreat where patients lived for a month to undergo extensive psychotherapy, meditation and community living.

He has a long interest in spirituality and psychotherapy, starting with psychedelics in the 1970s, going onto humanistic psychology in California, Vipassana, The Rajneesh Ashram in India and then experience with traditional healers and Sangomas in rural Zululand. He runs meditation and psychotherapy retreats and is Monash MAPS trained in MDMA assisted therapies. He is currently involved in an MDMA trial for PTSD in Perth.

Stephen extols cooperation and is open to all groups promoting safe and sensible Psychedelic-Assisted Therapies.

Dr David Erritzoe (UK)
Psychiatrist and Neuroscientist

Clinical Director in Centre for Psychedelic Research & Clinical Senior Lecturer in Psychiatry at Imperial College London

Dr. David Erritzoe is a psychiatrist and neuroscientist. He holds a Clinical Senior Lectureship (i.e. Assistant Professorship) in General Psychiatry in the Centres for Neuropsychopharmacology and Psychedelic Research at Imperial College London and CNWL Mental Health NHS Foundation Trust. Following training in neuroreceptor PET imaging at Columbia University in New York in 2002/03, he undertook a PhD at University Hospital Rigshospitalet in Copenhagen. Since moving to Imperial College in 2009 he has been conductingand overseeing clinical and neuroimaging trials (using PET, MRI, and EEG) into affective disorders and addiction. David is the Clinical Director of Imperial’s Centre for Psychedelic Research. Since early 2021 he has also headed up a new NHS-based research clinic at St Charles Hospital, the CIPPRes Clinic. He is topic lead in Psychiatry at Imperial College London’s Medical School, whilst also lecturing in MSc and BSc neuroscience programs. He has authored more than 110 peer-reviewed scientific papers and 4 book chapters.

Reece Flowers

Head of Training and Education at Mind Medicine Australia

Reece Flowers is a psychologist with a passion for guiding people through meaningful change. His career began in environmental advocacy and renewable energy, where he worked to address climate change before a shift into psychological science deepened his focus on human growth and transformation. Reece has worked across diverse settings, Including facilitating Dialectical Behaviour Therapy groups and delivering individual therapy. He now performs clinical research in psychedelic-assisted therapy.

With a predisposition for warmth and empathy, Reece helps clients navigate challenges such as depression, anxiety, trauma, and life transitions. He integrates evidence-based approaches with a strong interest in the emerging potential of psychedelic-assisted therapies, combining scientific knowledge with a deep respect for the nuances of everyone’s unique human experience.

Reece is committed to making psychological support more accessible through both individual therapy and broader community initiatives, empowering people to reconnect with themselves, their community, their values, and their capacity to thrive. Reece is a Graduate of Mind Medicine Australia’s Certificate in Psychedelic-Assisted Therapies.

Trudi Hayes

Mental Health Social Worker

Trudi Hayes lives on Gumbaynggirr Country at Missabotti. She is a mother of two children and is an accredited Mental Health Social Worker by trade. Trudi has worked in community development for the past 25 years and currently works in private practice, as a facilitator in workshops, trainings and retreat using Somatic processing, Breath Medicine and Kinesiology. Trudi believes that through working with the body, we can move patterns of behaviour that no longer serve us, achieving a sense of freedom and supporting connection with self, others and the natural world.

Scott Edwards

General Manager at Mind Medicine Australia Clinic

Scott Edwards is the Joint General Manager of the Mind Medicine Australia Clinic. Previously he was Executive Officer of Mind Medicine Australia delivering the organisation’s Psychedelic-Assisted Therapy Training & Education program, including its world-leading Certificate in Psychedelic-Assisted Therapies program. He also worked on the strategy and implementation of MMA’s successful advocacy initiative to reschedule MDMA and psilocybin.

He has been working in adult education for over 15 years, designing and implementing programs in the music and healthcare fields. In addition, he is a somatic facilitator and breathwork practitioner, working with a variety of techniques to support and integrate expanded states of awareness for therapeutic outcomes. He is the co-founder of Breath Medicine.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.